Moderna now authorized for ages 6 through 17

The Western States Scientific Safety Review Workgroup has weighed in to align with updated Centers for Disease Control and Prevention (CDC) recommendation for use of Moderna COVID-19 vaccine in children ages 6 to 17, giving more vaccine options for children and adolescents. Moderna's vaccine is already available for people ages 6 months through 5 years and 18 and older.

Providers who have received supply may immediately begin administering Moderna vaccine to children ages 6 to 17 years of age.

Updates for Moderna recommendations are as follows:

  • Children ages 6 years – 17 years receive a 2-dose primary series of Moderna COVID-19 vaccine
    • Dosage for children ages 6 – 11 administered as a two-dose series at 50 micrograms per dose
    • Dosage for children ages 12 - 17 administered as a two-dose series at 100 micrograms per dose
  • Note: Moderna is not authorized by the FDA for booster use at this time for those under 18 years old. FDA discussions on booster use are expected to be held this summer.
    • The Moderna booster vial dose can now also be used for the Moderna COVID-19 vaccine primary series for children ages 6-11.

Related article: Moderna Standing Orders for 6 months to 17 years old available

Topics Archive